These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9593595)

  • 1. Carvedilol inhibits activation of stress-activated protein kinase and reduces reperfusion injury in perfused rabbit heart.
    Yue TL; Ma XL; Gu JL; Ruffolo RR; Feuerstein GZ
    Eur J Pharmacol; 1998 Mar; 345(1):61-5. PubMed ID: 9593595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol.
    Yue TL; Ma XL; Wang X; Romanic AM; Liu GL; Louden C; Gu JL; Kumar S; Poste G; Ruffolo RR; Feuerstein GZ
    Circ Res; 1998 Feb; 82(2):166-74. PubMed ID: 9468187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of carvedilol and metoprolol on cardiac ischemia-reperfusion injury.
    Khandoudi N; Percevault-Albadine J; Bril A
    J Cardiovasc Pharmacol; 1998 Sep; 32(3):443-51. PubMed ID: 9733358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model.
    Feuerstein G; Liu GL; Yue TL; Cheng HY; Hieble JP; Arch JR; Ruffolo RR; Ma XL
    Eur J Pharmacol; 1998 Jun; 351(3):341-50. PubMed ID: 9721026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model.
    Gao F; Chen J; Lopez BL; Christopher TA; Gu J; Lysko P; Ruffolo RR; Ohlstein EH; Ma XL; Yue TL
    Eur J Pharmacol; 2000 Oct; 406(1):109-16. PubMed ID: 11011041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits.
    Ma XL; Yue TL; Lopez BL; Barone FC; Christopher TA; Ruffolo RR; Feuerstein GZ
    J Pharmacol Exp Ther; 1996 Apr; 277(1):128-36. PubMed ID: 8613909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the rat.
    Smith EF; Griswold DE; Hillegass LM; Slivjak MJ; Davis PA; DiMartino MJ
    Pharmacology; 1992; 44(6):297-305. PubMed ID: 1354874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.
    Asanuma H; Minamino T; Sanada S; Takashima S; Ogita H; Ogai A; Asakura M; Liao Y; Asano Y; Shintani Y; Kim J; Shinozaki Y; Mori H; Node K; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Jun; 109(22):2773-9. PubMed ID: 15148268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
    Ruffolo RR; Feuerstein GZ
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial protection with carvedilol.
    Feuerstein GZ; Hamburger SA; Smith EF; Bril A; Ruffolo RR
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S138-41. PubMed ID: 1378142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
    Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
    J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective effects of mast cell modulators in ischemia-reperfusion-induced injury in rats.
    Jaggi AS; Singh M; Sharma A; Singh D; Singh N
    Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):593-600. PubMed ID: 18193110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion.
    Ma XL; Kumar S; Gao F; Louden CS; Lopez BL; Christopher TA; Wang C; Lee JC; Feuerstein GZ; Yue TL
    Circulation; 1999 Apr; 99(13):1685-91. PubMed ID: 10190877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
    Bril A; Slivjak M; DiMartino MJ; Feuerstein GZ; Linee P; Poyser RH; Ruffolo RR; Smith EF
    Cardiovasc Res; 1992 May; 26(5):518-25. PubMed ID: 1359930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carvedilol improves function and reduces infarct size in the feline myocardium by protecting against lethal reperfusion injury.
    Brunvand H; Frłyland L; Hexeberg E; Rynning SE; Berge RK; Grong K
    Eur J Pharmacol; 1996 Oct; 314(1-2):99-107. PubMed ID: 8957224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of carvedilol against myocardial injury due to ischemia-reperfusion of the brain in rats.
    Harima M; Arumugam S; Wen J; Pitchaimani V; Karuppagounder V; Afrin MR; Sreedhar R; Miyashita S; Nomoto M; Ueno K; Nakamura M; Watanabe K
    Exp Mol Pathol; 2015 Jun; 98(3):558-62. PubMed ID: 25872160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SB 211475, a metabolite of carvedilol, reduces infarct size after myocardial ischemic and reperfusion injury in rabbits.
    Brunvand H; Liu G; Ma XL; Yue TL; Ruffolo RR; Feuerstein GZ
    Eur J Pharmacol; 1998 Sep; 356(2-3):193-8. PubMed ID: 9774249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of cardioprotective effect by postconditioning in coronary stenosed rat heart and its restoration by carvedilol.
    Oikawa M; Yaoita H; Watanabe K; Maruyama Y
    Circ J; 2008 Dec; 72(12):2081-6. PubMed ID: 18946174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotection by Carvedilol: antiapoptosis is independent of beta-adrenoceptor blockage in the rat heart.
    Schwarz ER; Kersting PH; Reffelmann T; Meven DA; Al-Dashti R; Skobel EC; Klosterhalfen B; Hanrath P
    J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):207-15. PubMed ID: 14506546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol treatment after myocardial infarct decreases cardiomyocytic apoptosis in the peri-infarct zone during cardioplegia-induced cardiac arrest.
    Yeh CH; Chen TP; Wang YC; Lin YM; Fang SW
    Shock; 2013 Apr; 39(4):343-52. PubMed ID: 23481492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.